ReviewInterventional radiology (Higashimatsuyama-shi (Japan)2026
Prostatic Artery Embolization with Cyanoacrylate Glue for Benign Prostatic Hyperplasia: A Systematic Review and Single-arm Meta-analysis of Short-term Outcomes.
Review in Interventional radiology (Higashimatsuyama-shi (Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review and single-arm meta-analysis synthesized evidence on the safety and efficacy of prostatic artery embolization with cyanoacrylate glue for benign prostatic hyperplasia. PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched, and eight studies comprising 723 patients were included. Clinically meaningful improvements were observed in International Prostate Symptom Score (-10.44), prostate volume (-25.56 mL), and International Prostate Symptom Score-Quality of Life (-2.52). Subgroup analyses of follow-up up to 6 months showed no significant differences compared with longer follow-up. Adverse events occurred in 13% of patients. Mean fluoroscopy time was 26.64 minutes, and mean radiation exposure was 105.82 Gy·cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.